Latest

Happiest Health Appoints Dr Sreenivasan Narayana as President & CEO of Healthcare Services Division

Bengaluru, July 03, 2024: Happiest Health announced the appointment of Dr Sreenivasan Narayana as President & Chief Executive Officer of the knowledge, health and wellness enterprise’s new division – Healthcare Services. This will help Happiest Health to strengthen its offerings in the healthcare services sector.

Dr Sreenivasan will be responsible for strategic planning, operations, and the development of new healthcare service centres.

Dr Sreenivasan Narayana is an ENT surgeon who has worked in renowned healthcare organisations such as the Apollo Hospitals Group and Narayana Health. He also founded Doctree Health, a start-up aimed at affordable treatments. Dr Sreenivasan completed his postgraduate program in management at the Indian School of Business, Hyderabad, where he undertook a full semester exchange MBA programme at The Wharton School, USA.

Speaking on the appointment, Davis Karedan, co-chairman of Happiest Health, said, “We are pleased  to welcome Dr Sreenivasan (Sreeni) to the Happiest Health team. His appointment represents a significant milestone as we expand our presence in the health and wellness sector. With the appointment of Sreeni, we have filled all our 4 division head positions at Happiest Health: knowledge, diagnostics, healthcare and wellness.”

Dr Sreenivasan Narayana expressed enthusiasm about his new role, stating, “I am delighted to be a part of the Happiest Health family. The company’s goals and vision for healthcare in the country resonate strongly with my own, and I believe we can accomplish a lot together. I look forward to working with the fantastic team and taking Happiest Health to greater heights.”

Ashok Soota, Chairman of Happiest Health, said, “Dr Sreenivasan joins Happiest Health with a wealth of expertise, experience and ideas. The synergy between our knowledge, diagnostics, healthcare and wellness businesses will help Happiest Health to progress towards its goal of doing an IPO in 6 years.”.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Mental Health and Cancer: Navigating Emotional Well-being

By Dr. Arijit Bishnu, MBBS, MD, DM Associate Consultant, Hemato-Oncology &BMT,HCG EKO Cancer Centre, Newtown,…

1 day ago

AstraZeneca plans to invest Rs 250 crore to grow its Global Innovation and Technology Centre in India, bringing some 1,300 highly skilled roles by 2025

India, July 04, 2024: AstraZeneca India Private Limited (AZIPL), the Global Capability Centre (GCC) of…

3 days ago

10 Essential Facts You Need to Know About Prostate Cancer

By Prof. Dr. Somashekhar S P, Chairman - Medical Advisory Board, Aster DM Healthcare - GCC…

1 week ago

Sarvodaya Hospital successfully treats India’s 2nd youngest child from severe hearing loss through Cochlear Implant

Faridabad, June 28, 2024: Furthering their commitment to serving the community through affordable and compassionate…

1 week ago

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home2/theprkho/public_html/thepharmatimes.in/wp-includes/functions.php on line 5420